Cargando…
Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523569/ https://www.ncbi.nlm.nih.gov/pubmed/37771593 http://dx.doi.org/10.3389/fimmu.2023.1283355 |
_version_ | 1785110589428727808 |
---|---|
author | Myers, Mallory L. Gallagher, John R. Woolfork, De’Marcus D. Stradtmann-Carvalho, Regan K. Maldonado-Puga, Samantha Bock, Kevin W. Boyoglu-Barnum, Seyhan Syeda, Hubza Creanga, Adrian Alves, Derron A. Kanekiyo, Masaru Harris, Audray K. |
author_facet | Myers, Mallory L. Gallagher, John R. Woolfork, De’Marcus D. Stradtmann-Carvalho, Regan K. Maldonado-Puga, Samantha Bock, Kevin W. Boyoglu-Barnum, Seyhan Syeda, Hubza Creanga, Adrian Alves, Derron A. Kanekiyo, Masaru Harris, Audray K. |
author_sort | Myers, Mallory L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10523569 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105235692023-09-28 Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus Myers, Mallory L. Gallagher, John R. Woolfork, De’Marcus D. Stradtmann-Carvalho, Regan K. Maldonado-Puga, Samantha Bock, Kevin W. Boyoglu-Barnum, Seyhan Syeda, Hubza Creanga, Adrian Alves, Derron A. Kanekiyo, Masaru Harris, Audray K. Front Immunol Immunology Frontiers Media S.A. 2023-09-12 /pmc/articles/PMC10523569/ /pubmed/37771593 http://dx.doi.org/10.3389/fimmu.2023.1283355 Text en Copyright © 2023 Myers, Gallagher, Woolfork, Stradtmann-Carvalho, Maldonado-Puga, Bock, Boyoglu-Barnum, Syeda, Creanga, Alves, Kanekiyo and Harris https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Myers, Mallory L. Gallagher, John R. Woolfork, De’Marcus D. Stradtmann-Carvalho, Regan K. Maldonado-Puga, Samantha Bock, Kevin W. Boyoglu-Barnum, Seyhan Syeda, Hubza Creanga, Adrian Alves, Derron A. Kanekiyo, Masaru Harris, Audray K. Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus |
title | Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus |
title_full | Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus |
title_fullStr | Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus |
title_full_unstemmed | Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus |
title_short | Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus |
title_sort | corrigendum: impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous yamagata-lineage influenza b virus |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523569/ https://www.ncbi.nlm.nih.gov/pubmed/37771593 http://dx.doi.org/10.3389/fimmu.2023.1283355 |
work_keys_str_mv | AT myersmalloryl corrigendumimpactofadjuvanttrivalentvaccinewithquadrivalentlikeprotectionagainstheterologousyamagatalineageinfluenzabvirus AT gallagherjohnr corrigendumimpactofadjuvanttrivalentvaccinewithquadrivalentlikeprotectionagainstheterologousyamagatalineageinfluenzabvirus AT woolforkdemarcusd corrigendumimpactofadjuvanttrivalentvaccinewithquadrivalentlikeprotectionagainstheterologousyamagatalineageinfluenzabvirus AT stradtmanncarvalhoregank corrigendumimpactofadjuvanttrivalentvaccinewithquadrivalentlikeprotectionagainstheterologousyamagatalineageinfluenzabvirus AT maldonadopugasamantha corrigendumimpactofadjuvanttrivalentvaccinewithquadrivalentlikeprotectionagainstheterologousyamagatalineageinfluenzabvirus AT bockkevinw corrigendumimpactofadjuvanttrivalentvaccinewithquadrivalentlikeprotectionagainstheterologousyamagatalineageinfluenzabvirus AT boyoglubarnumseyhan corrigendumimpactofadjuvanttrivalentvaccinewithquadrivalentlikeprotectionagainstheterologousyamagatalineageinfluenzabvirus AT syedahubza corrigendumimpactofadjuvanttrivalentvaccinewithquadrivalentlikeprotectionagainstheterologousyamagatalineageinfluenzabvirus AT creangaadrian corrigendumimpactofadjuvanttrivalentvaccinewithquadrivalentlikeprotectionagainstheterologousyamagatalineageinfluenzabvirus AT alvesderrona corrigendumimpactofadjuvanttrivalentvaccinewithquadrivalentlikeprotectionagainstheterologousyamagatalineageinfluenzabvirus AT kanekiyomasaru corrigendumimpactofadjuvanttrivalentvaccinewithquadrivalentlikeprotectionagainstheterologousyamagatalineageinfluenzabvirus AT harrisaudrayk corrigendumimpactofadjuvanttrivalentvaccinewithquadrivalentlikeprotectionagainstheterologousyamagatalineageinfluenzabvirus |